Cargando…
Use of combination therapy in the treatment of primary osteoporosis: protocol for a network meta-analysis of randomised trials
INTRODUCTION: The existing medications approved for treatment of primary osteoporosis can be divided into antiresorptive drugs and anabolic drugs. According to the mechanisms of action, the combined therapy may produce a synergistic effect on bone mineral density (BMD) compared with monotherapy, and...
Autores principales: | Lou, Shenghan, Lv, Houchen, Chen, Yuxiang, Zhang, Licheng, Tang, Peifu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128987/ https://www.ncbi.nlm.nih.gov/pubmed/28186942 http://dx.doi.org/10.1136/bmjopen-2016-012802 |
Ejemplares similares
-
Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials
por: Lou, Shenghan, et al.
Publicado: (2018) -
The effect of sequential therapy for postmenopausal women with osteoporosis: A PRISMA-compliant meta-analysis of randomized controlled trials
por: Lou, Shenghan, et al.
Publicado: (2016) -
Parathyroid hormone analogues for fracture healing: protocol for a systematic review and meta-analysis of randomised controlled trials
por: Lou, Shenghan, et al.
Publicado: (2018) -
The effects of low-intensity pulsed ultrasound on fresh fracture: A meta-analysis
por: Lou, Shenghan, et al.
Publicado: (2017) -
The Effect of Teriparatide on Fracture Healing of Osteoporotic Patients: A Meta-Analysis of Randomized Controlled Trials
por: Lou, Shenghan, et al.
Publicado: (2016)